Home › Non-Hodgkin Lymphoma › District of Columbia
Non-Hodgkin Lymphoma clinical trials in District of Columbia
4 studies for Non-Hodgkin Lymphoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Medstar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's National Medical Center, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.